News / Events

FDA Publishes Final Rule on New Regulatory Pathway Shift for Insulin, Other Biologics

Country: UNITED STATES | Region: NORTH AMERICA | Type: Policy | Keywords: #biologicdrugs #biosimilar #fda #insulin #regulation PRICENTRIC BRIEF: On March 23, 2020, an application for a biological product approved under the Federal Food, Drug, and Cosmetic Act (FD&C Act), including applications for insulin and other biological products, will be deemed to be a license for the product under the Public Health Service (PHS) Act For the first […]

ClinBiz Summit 2020

Connect with top-notch industry speakers  delivering impactful presentations with practical solutions and best practices to take you to the next level in leading and managing the business aspects of clinical trials. Meet the EVERSANA team to learn how we can help drive awareness programs, education and support services to promote adherence and better health outcomes. […]

Denmark, Iceland, & Norway Conclude First Joint Nordic Tendering

Country: DENMARK, ICELAND, NORWAY | Region: EUROPE, NORDICS | Type: Tender | Keywords: #generics #jointprocurement #nordictendering #patentexpiry #suppliers PRICENTRIC BRIEF: The first joint Nordic tendering intended to combine Denmark, Iceland, and Norway into “one large, attractive Nordic market for selected hospital pharmaceuticals,” particularly older medicines with expired patents that have been on the market for some time and have little competition Bente Hayes, Procurement Director at Norge Sykenusinnkjop HF, Divisjon Legemidler, […]

Spain Authorizes Centralized Purchase of 391 Million Euros Worth of Medicines

Country: SPAIN | Region: EUROPE | Type: Regulation | Keywords: #antianemicagents #antineoplasticagents #centralizedpurchase #immunomodulatoryagents #immunosuppressants #sns PRICENTRIC BRIEF: The Council of Ministers has authorized the centralized purchase of 391 million euros worth of medicines under which manufacturers will be selected to supply different active principles at an estimated savings of 128 million euros for Spain’s National Health System (SNS) Spain is looking primarily at immunosuppressants for autoimmune diseases […]

EVERSANA™ unveils EVERSANA CONSULTING, portfolio of consulting services to solve challenges across the life sciences sector

CHICAGO – February 6, 2020  – Fueled by the growing demand for seasoned consulting expertise, EVERSANA™, the leading independent provider of commercial services to the life sciences industry, today unveiled EVERSANA CONSULTING, the new name of its global consulting services focused on the pharmaceutical and biotechnology industries. EVERSANA CONSULTING is built to address challenges across […]

FDA Releases Guidance on Gene Therapy Manufacturing, Clinical Development

Country: UNITED STATES | Region: NORTH AMERICA | Type: Policy | Keywords: #clinicaldevelopment #fda #genetherapy #guidance PRICENTRIC BRIEF: The Food and Drug Administration has approved 4 gene therapy products thus far, and anticipates many more approvals in the coming years, as evidenced by the more than 900 investigational new drug (IND) applications for ongoing clinical studies in this area To support the continued development of gene therapies, […]

Ireland’s Pharma Industry Group Urges Parties Create New Medicines Policy

Country: IRELAND | Region: EUROPE | Type: Policy | Keywords: #hse #ipha #newmedicinespolicy #patientaccess #pricingandreimbursement #sustainability PRICENTRIC BRIEF: The Irish Pharmaceutical Healthcare Association (IPHA), the representative body of the international originator biopharmaceutical industry in Ireland, has urged all political parties to pledge to improve patients’ access to new medicines as part of their plans for health during general elections Ireland is among the slowest in Western Europe to provide […]

Evoke Pharma Enters Commercialization Agreement with EVERSANA for Gimoti™

EVERSANA to commercialize and distribute Gimoti in the U.S. EVERSANA to provide $5 million revolving credit facility upon FDA approval SOLANA BEACH, CA, and CHICAGO, IL. January 23, 2020 – Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, and EVERSANA™, an independent provider of global commercial services […]

China Wraps Up Round 2 of Centralized Drug

PurchaseCountry: CHINA | Region: ASIA & SOUTH PACIFIC | Type: Regulation | Keywords: #bmi #drugpurchase #nhsa #pricereductions #shanghaidrugpurchasenetwork #tender PRICENTRIC BRIEF: The Shanghai Drug Purchase Network, the National Health Security Administration’s (NHSA) executive for Round 2 of the National Level Centralized Drug Purchase Program, announced that Round 2 includes the purchase of 33 drugs regarding 50 specifications According to Chinese media, the average price reduction by prevailing suppliers […]

Meet the Experts of High-Touch Patient Recruitment & Engagement

Today’s patients are far more engaged than the previous era of “doctor knows best.” Powered by the technology they use in their daily lives, the patient community is partnering with providers, scientists, regulators, disease state experts, and manufacturers to: Design clinically meaningful endpoints Engage and educate online communities Improve disease awareness and diagnosis Co-design patient […]